Е. Л. Насонов

4.9k total citations · 1 hit paper
399 papers, 3.2k citations indexed

About

Е. Л. Насонов is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Е. Л. Насонов has authored 399 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 278 papers in Rheumatology, 104 papers in Immunology and 63 papers in Hematology. Recurrent topics in Е. Л. Насонов's work include Rheumatoid Arthritis Research and Therapies (157 papers), Systemic Lupus Erythematosus Research (152 papers) and Monoclonal and Polyclonal Antibodies Research (53 papers). Е. Л. Насонов is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (157 papers), Systemic Lupus Erythematosus Research (152 papers) and Monoclonal and Polyclonal Antibodies Research (53 papers). Е. Л. Насонов collaborates with scholars based in Russia, United States and United Kingdom. Е. Л. Насонов's co-authors include Juan J. Gómez‐Reino, Mark C. Genovese, Eduardo Mysler, James D. McKay, Nilzio A Da Silva, Emma Alecock, Thasia Woodworth, А. М. Лила, Samsonov MIu and А. С. Авдеева and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Е. Л. Насонов

316 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy study

2008 655 citations Е. Л. Насонов, Juan J. Gómez‐Reino et al. profile →

Peers

Е. Л. Насонов

RHEUM

IMMUN

HEMAT

ONCOL

Rolf Rau Germany

Matija Tomšič Slovenia

Michel De Bandt France

Francesco Carubbi Italy

Mami Tamai Japan

Barbara Tolusso Italy

Cédric Lukas France

İhsan Ertenli Türkiye

Onorina Berardicurti Italy

Shigeki Momohara Japan

Rolf Rau Germany

Е. Л. Насонов

2.4k ×1.1

RHEUM

770 ×0.9

IMMUN

963 ×1.2

HEMAT

405 ×0.9

298 ×0.9

ONCOL

Citations per year, relative to Е. Л. Насонов Е. Л. Насонов (= 1×) peers Rolf Rau

Countries citing papers authored by Е. Л. Насонов

Since Specialization

Citations

This map shows the geographic impact of Е. Л. Насонов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Е. Л. Насонов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Е. Л. Насонов more than expected).

Fields of papers citing papers by Е. Л. Насонов

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Е. Л. Насонов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Е. Л. Насонов. The network helps show where Е. Л. Насонов may publish in the future.

Co-authorship network of co-authors of Е. Л. Насонов

This figure shows the co-authorship network connecting the top 25 collaborators of Е. Л. Насонов. A scholar is included among the top collaborators of Е. Л. Насонов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Е. Л. Насонов. Е. Л. Насонов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Елисеев, М. С. & Е. Л. Насонов. (2024). Treatment and diagnostics of gout: Unsolved problems in clinical practice. SHILAP Revista de lepidopterología. 62(1). 7–12. 2 indexed citations

Баранов, А. А., et al.. (2024). Lupus nephritis. Part II, modern ideas about therapy. SHILAP Revista de lepidopterología. 62(4). 377–384. 1 indexed citations

Imazio, Massimo, М. А. Саидова, & Е. Л. Насонов. (2024). Complex Issues in the Management of Pericarditis. In Anticipation of the Release of Updated Recommendations of the European Society of Cardiology. Kardiologiia. 64(10). 57–61. 1 indexed citations

Насонов, Е. Л.. (2023). Autoimmunity in rheumatology: A review. Terapevticheskii arkhiv. 95(12). 1056–1063.

Насонов, Е. Л.. (2023). Modern concept of autoimmunity in rheumatology. SHILAP Revista de lepidopterología. 61(4). 397–420. 12 indexed citations

Насонов, Е. Л., et al.. (2023). Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease. SHILAP Revista de lepidopterología. 61(3). 276–291. 5 indexed citations

Баранов, А. А., Е. А. Богданова, Е. П. Иливанова, et al.. (2023). Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab). SHILAP Revista de lepidopterología. 61(3). 307–319. 2 indexed citations

Елисеев, М. С., et al.. (2021). Advantages of the use of metformin in patients with impaired uric acid metabolism. Terapevticheskii arkhiv. 93(5). 71520–71520. 6 indexed citations

Насонов, Е. Л., et al.. (2021). Anxiety, depression and stress tension screening in patients with rheumatic and musculoskeletal diseases at the onset of the 2019 coronavirus disease (COVID-19) pandemic. SHILAP Revista de lepidopterología. 59(6). 676–683. 3 indexed citations

10.

Насонов, Е. Л., et al.. (2021). The effect of olokizumab on rheumatoid arthritis patient’s reported outcomes: results of a double-blind randomized placebo-controlled multicenter phase III trial (CREDO 1). SHILAP Revista de lepidopterología. 59(1). 62–69. 5 indexed citations

11.

Alekberova, Z S & Е. Л. Насонов. (2020). PROSPECTS FOR USING COLCHICINE IN MEDICINE: NEW EVIDENCE. SHILAP Revista de lepidopterología. 58(2). 183–190. 12 indexed citations

12.

Александрова, Е Н, et al.. (2016). DUAL THERAPY WITH BIOLOGICALS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. SHILAP Revista de lepidopterología. 7 indexed citations

13.

Авдеева, А. С., А. А. Новиков, Е Н Александрова, et al.. (2014). CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY). SHILAP Revista de lepidopterología. 1 indexed citations

14.

Александрова, Е Н, et al.. (2014). Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment. SHILAP Revista de lepidopterología. 1 indexed citations

15.

Смирнов, А. В., et al.. (2014). [Association between bone mineral density and erosive and destructive changes in patients with rheumatoid arthritis: preliminary results].. PubMed. 86(5). 10–7. 1 indexed citations

16.

Patrushev, Lev I., et al.. (2013). Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome. SHILAP Revista de lepidopterología. 1 indexed citations

17.

Насонов, Е. Л., et al.. (2012). CURRENT TRENDS IN CLASSIFICATION AND TREATMENT OF SYSTEMIC VASCULITIS ASSOCIATED WITH ANTI-NEUTROPHILIC CYTOPLASMIC ANTIBODIES: RESULTS OF 2011. SHILAP Revista de lepidopterología. 1 indexed citations

18.

Westhovens, René, Filip De Keyser, Е. Л. Насонов, et al.. (2011). A twelve-week exploratory phase II trial of GLPG0259 versus placebo in patients with active rheumatoid arthritis and inadequate response to methotrexate. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

19.

Chatzidionysiou, Katerina, Elisabeth Lie, Е. Л. Насонов, et al.. (2011). Efficacy of different doses of rituximab for the treatment of rheumatoid arthritis: Data from the CERERRA collaboration.. Research at the University of Copenhagen (University of Copenhagen). 1 indexed citations

20.

Попкова, Т. В., Е Н Александрова, Д. С. Новикова, et al.. (2008). Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection. SHILAP Revista de lepidopterología. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact